Global Structural Heart Devices Market Share Is Expected To Grow At A CAGR Of 10.35% By 2030

01-Feb-2023 | Facts and Factors

According to Facts and Factors, the global structural heart devices market size was worth around USD 10.3 billion in 2021 and is predicted to grow to around USD 20 billion by 2030 with a compound annual growth rate (CAGR) of roughly 10.35% between 2022 and 2030.

Structural heart diseases refer to cardiac conditions that occur due to defects in the heart's structure for instance the valves. Structural heart diseases may be due to genetic defects, be present from the time of birth or it can arise as a consequence of aging or other underlying diseases which lead to wear and tear of the heart in later stages of life. A normal or healthy heart beats around 100,000 times per day. With every beat, it supplies nutrient and oxygen-rich blood to different parts of the body.

Browse the full “Structural Heart Devices Market Size, Share, Growth Analysis Report By Indication (Cardiomyopathy and Valvular Heart Disease), By Type (Delivery Systems, Heart Valve Devices, Occluders, and Annuloplasty Rings), By Procedure (Repair Procedures and Replacement Procedures), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030" report at https://www.fnfresearch.com/structural-heart-devices-market

During the beating process, the heart contracts and relaxes which is the main cause of blood flow that passes through the four chambers or valves of the heart. The chambers regulate the blood flow in the body and structural disease can occur if any of these components show any kind of abnormality or defect in their structure including chambers, valves, walls, and muscle, along with major arteries that are responsible for blood transportation.

The global structural heart devices market is projected to grow owing to increasing investments in the development of new and enhanced devices. Earlier, any surgery or operation related to the heart was conducted under extreme supervision since it generally required long processes to be carried out during the procedure. However, with time and consistent work toward deploying advanced technologies, cardiac treatment has become minimally invasive which means that the patients are not exposed to a lot of post-operative issues. Cardiomyopathy is a common structural heart disease that affects the muscles of the heart making it harder for it to pump blood.

During the diagnosis process, the medical professional uses techniques like X-ray, treadmill stress test, echocardiogram, cardiac catheterization, electrocardiogram, and cardiac magnetic resonance imaging (MRI) to confirm if the condition really exists and its severity. The goal of the associated treatment plan is to manage the symptom while also preventing the condition from deteriorating, and reducing the complication risks. The medication will also depend on the type and severity of the cardiomyopathy.

The global market may face growth restrictions due to the presence of stringent regulations surrounding the approval and use of structural heart devices. In certain regions, the approval process is extremely strict and lengthy since this equipment is introduced in the body. The process may also require high investment since several steps are involved until reaching the end result. The US Food and Drugs Administration (FDA) classified structural heart devices as Class III equipment. 70 to 80% of the commercialization cost of the devices can be linked to the FDA approval process.

Segmental Overview

The increasing investments in healthcare could create growth opportunities while the associated risks may pose major challenges during the expansion phase.

The global structural heart devices market is segmented based on indication, type, procedure, and region

Based on type, the global market divisions are delivery Systems, heart valve devices, occluders, and annuloplasty rings. The global market registered the highest growth in the heart valve devices segment due to the high number of valve-related procedures conducted across the globe. There are various options present in the medical sector for valve structures including manufactures mechanical valves, donor valve implantation, and tissue valve.

The artificially created valves are made of extremely durable and strong materials and in the case of replacement surgeries, they are the most widely used valve replacements that can save a patient's life. However, the person who gets implanted with an artificial valve will have to depend on medication meant for blood thinning for the rest of their life. A single valve replacement cost can be around USD 100 to USD 200

Based on procedure, the global market is segmented into repair procedures and replacement procedures. The global market registered the highest demand for repair procedures since replacement activities are known to reduce the heart’s functioning capabilities.

In replacement processes, the patient is allowed to keep the valve and the survival rate. The bleeding risk gets significantly reduced which results in higher postoperative patient safety. The Cleveland Clinic states that the durable solution for mitral valve disease is the repair process and almost 90% of repaired valve cases can last up to 20 years.

Regional Overview

North America is projected to lead the global structural heart devices market owing to the growing FDA approvals in the US assisting the growing number of surgeries related to structural heart diseases. The European market is anticipated to be led by the rise in the number of patients suffering from cardiac issues. European nations have become popular in recent times for heart-related operations due to the high success rate and excellent medical facilities. Growth in Asia-Pacific could be led by the growing investments in the healthcare sector and the merging number of domestic players in the regional market.

Report Scope

Competitive Landscape

The global structural heart devices market is dominated by players like Boston Scientific Corporation, St. Jude Medical, Inc., Edwards Lifesciences Corporation, Medtronic plc, Cryolife, Inc., Medical Technology Est., and others.

Recent Developments:

• In November 2022, Venus Medtech announced that it will showcase its exciting line of treatments for structural heart diseases at the ExCeL London 2022
• In May 2021, Abbott announced that it had received the Conformité Européenne (CE) mark for its latest generation transcatheter system for aortic valve implantation, called NAVITOR

The global structural heart devices market is segmented as follows:

By Indication

• Cardiomyopathy
• Valvular Heart Disease

By Type

• Delivery Systems
• Heart Valve Devices
• Occluders
• Annuloplasty Rings

By Procedure

• Repair Procedures
• Replacement Procedures

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com